Pierrefonds, Canada

Philip J Vickers

This inventor holds 4 USPTO granted patents. Top assignee: Merck Frosst Canada, Inc.. Active years: 1995-2007.


% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 243(Granted Patents)


Location History:

  • Pierrefonds, CA (1995 - 1996)
  • Westborough, MA (US) (2007)

Company Filing History:


Years Active: 1995-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Philip J Vickers

Introduction

Philip J Vickers is a notable inventor based in Pierrefonds, Canada. He has made significant contributions to the field of biotechnology, particularly in the area of cyclooxygenase research. With a total of 4 patents to his name, Vickers has demonstrated a commitment to advancing scientific knowledge and technology.

Latest Patents

Among his latest patents is the invention titled "Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity." This invention discloses a human cyclooxygenase-2 cDNA, a human cyclooxygenase-2, and assays for preferentially and independently measuring cyclooxygenase-2 or cyclooxygenase-1 activity present in a given sample. This innovation is crucial for understanding the role of cyclooxygenase-2 in various biological processes and diseases.

Career Highlights

Philip J Vickers is currently associated with Merck Frosst Canada, Inc., where he continues to work on groundbreaking research. His expertise in biotechnology has positioned him as a key figure in the development of new therapeutic approaches.

Collaborations

Throughout his career, Vickers has collaborated with esteemed colleagues such as Joseph A Mancini and Gary P O'Neill. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Philip J Vickers is a distinguished inventor whose work in biotechnology has led to significant advancements in the understanding of cyclooxygenase-2. His contributions continue to impact the field and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…